Estrogen potencies of three new low-dose oral contraceptives

The estrogen potencies of three new oral contraceptive formulations—Brevicon, Modicon, and Lo/Ovral—were determined. Brevicon and Modicon were found to have estrogen potency equal to mestranol 50 μg and equal to or greater than Norinyl 1 + 50 and Ortho-Novum 1 + 50, Lo/Ovral, which is identical to O...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of obstetrics and gynecology 1976-08, Vol.125 (7), p.976-979
Hauptverfasser:	Dickey, Richard P., Weems Chihal, H.J., Peppler, Richard D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biological Assay Contraceptives, Oral - analysis Dose-Response Relationship, Drug Drug Combinations Estrogens - analysis Ethinyl Estradiol - pharmacology Female Mestranol - pharmacology Mice Norethindrone - pharmacology Norgestrel - pharmacology Progestins - analysis Uterus - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!